MY193248A - Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation - Google Patents

Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation

Info

Publication number
MY193248A
MY193248A MYPI2018001315A MYPI2018001315A MY193248A MY 193248 A MY193248 A MY 193248A MY PI2018001315 A MYPI2018001315 A MY PI2018001315A MY PI2018001315 A MYPI2018001315 A MY PI2018001315A MY 193248 A MY193248 A MY 193248A
Authority
MY
Malaysia
Prior art keywords
inflammation
compositions
treatment
bacterial strain
lactobacillus plantarum
Prior art date
Application number
MYPI2018001315A
Other languages
English (en)
Inventor
Jorg Thilo Fischer
Marcus Rudolf Gotz
Goran Molin
Siv Ahrne
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of MY193248A publication Critical patent/MY193248A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
    • C12N11/04—Enzymes or microbial cells immobilised on or in an organic carrier entrapped within the carrier, e.g. gel or hollow fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A23V2200/3204—Probiotics, living bacteria to be ingested for action in the digestive tract
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Virology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Dispersion Chemistry (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
MYPI2018001315A 2016-01-19 2017-01-18 Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation MY193248A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1600975.5A GB201600975D0 (en) 2016-01-19 2016-01-19 Novel strain of probiotic bacteria and compositions and uses thereof
PCT/EP2017/051003 WO2017125446A1 (en) 2016-01-19 2017-01-18 Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation

Publications (1)

Publication Number Publication Date
MY193248A true MY193248A (en) 2022-09-28

Family

ID=55488176

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2018001315A MY193248A (en) 2016-01-19 2017-01-18 Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation

Country Status (22)

Country Link
US (1) US10893695B2 (enExample)
EP (1) EP3405263B1 (enExample)
JP (1) JP6899400B2 (enExample)
KR (1) KR102904068B1 (enExample)
CN (1) CN108738308B (enExample)
AU (1) AU2017209867B2 (enExample)
BR (1) BR112018014654B1 (enExample)
CA (1) CA3011322C (enExample)
CL (1) CL2018001936A1 (enExample)
DK (1) DK3405263T3 (enExample)
ES (1) ES2875765T3 (enExample)
GB (1) GB201600975D0 (enExample)
MX (1) MX393766B (enExample)
MY (1) MY193248A (enExample)
PH (1) PH12018550110B1 (enExample)
PL (1) PL3405263T3 (enExample)
PT (1) PT3405263T (enExample)
RS (1) RS61954B1 (enExample)
RU (1) RU2729420C2 (enExample)
SG (1) SG11201806057QA (enExample)
WO (1) WO2017125446A1 (enExample)
ZA (1) ZA201804863B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017209868B2 (en) * 2016-01-19 2023-08-03 Probi Ab Probiotics for use as anti-inflammatory agents in the oral cavity
AU2018428571B2 (en) * 2018-06-18 2025-06-26 Probi Ab Lactobacillus plantarum compositions and uses thereof
WO2020001747A1 (en) 2018-06-26 2020-01-02 Symrise Ag Lactobacillus plantarum for skin care
JP7489045B2 (ja) * 2018-09-25 2024-05-23 国立研究開発法人国立循環器病研究センター 抗腫瘍効果増強剤
CN111996137B (zh) * 2020-08-07 2022-08-05 华东理工大学 一株植物乳杆菌
CN113234639B (zh) * 2021-06-16 2022-08-30 广东海天创新技术有限公司 一株植物乳杆菌zf632及其应用
US12414972B2 (en) * 2021-10-26 2025-09-16 University Of South Florida Human origin probiotic lactobacillus rhamnosus HL-200 to reduce leaky gut by metabolizing ethanolamine
CN114672480A (zh) * 2022-04-29 2022-06-28 浙江工商大学 植物乳杆菌凝胶珠及其制备方法

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518615A (en) 1983-08-23 1985-05-21 Warner-Lambert Company Non-adhesive chewing gum base composition
US4721620A (en) 1986-04-01 1988-01-26 Warner-Lambert Company Polyvinylacetate bubble gum base composition
US5093136A (en) 1991-05-08 1992-03-03 Nabisco Brands, Inc. Dual gum base bubble gum
US5266336A (en) 1991-11-12 1993-11-30 Wm. Wrigley Jr. Company High flavor impact non-tack chewing gum with reduced plasticization
US5601858A (en) 1994-12-29 1997-02-11 Warner-Lambert Company Non-stick chewing gum
EP1117414A1 (en) 1998-10-01 2001-07-25 Probi Ab Reduction of oxidative stress factors
IT1306716B1 (it) 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.
US6849256B1 (en) 1999-11-08 2005-02-01 Ganeden Biotech Incorporated Inhibition of pathogens by probiotic bacteria
US20040101495A1 (en) 2002-11-27 2004-05-27 Leena Nase Method for improving dental health
SE527555C2 (sv) 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
KR101300086B1 (ko) 2005-10-06 2013-08-30 프로비 아베 자가면역질환의 치료를 위한 락토바실러스의 용도
EP2046352A4 (en) 2006-06-06 2012-03-21 Univ Mcgill Fermented milk product and use thereof
RU2009133376A (ru) 2007-03-27 2011-05-10 Дзе Проктер Энд Гэмбл Компани (US) Способы и наборы для введения пробиотиков
CN102123604A (zh) 2008-06-24 2011-07-13 Wm.雷格利Jr.公司 益生菌口香糖的制造方法
WO2010064373A1 (ja) * 2008-12-04 2010-06-10 国立大学法人広島大学 Ｉｌ－８阻害剤およびその製造方法
JP2012512171A (ja) 2008-12-16 2012-05-31 ネステク ソシエテ アノニム 改善された口腔健康のための組成物及び方法
JP5337535B2 (ja) * 2009-03-02 2013-11-06 日本ルナ株式会社 Ｎｋ活性増強剤
ES2778836T3 (es) * 2009-03-05 2020-08-12 Probiotical Spa Cepas de bacterias que tienen una alta actividad antiinflamatoria
KR101100043B1 (ko) * 2009-06-29 2011-12-29 주식회사한국야쿠르트 항염증 효능을 갖는 락토바실러스 플란타룸 에이취와이7711 및 이를 유효성분으로 함유하는 제품
DE202009011379U1 (de) * 2009-08-24 2010-12-30 Khalifa, Samir Orale Präparate zur Mund- und Zahnpflege und Bekämpfung von Mundgeruch
EP2420580A1 (en) * 2010-08-18 2012-02-22 AB-Biotics, S.A. Probiotic composition for oral health
US9308227B2 (en) 2011-05-16 2016-04-12 Organobalance Medical Ag Lactic acid bacteria and compositions containing them against bacterial colds
JP5904028B2 (ja) * 2012-06-19 2016-04-13 ライオン株式会社 乳酸菌及びその培養由来物、ならびにこれらを含有する組成物
CA2783414A1 (en) * 2012-07-22 2014-01-22 Integral Medical Inc. Probiotic composition
RU2492851C1 (ru) * 2012-08-02 2013-09-20 Сергей Владимирович Кузнецов Способ профилактики и лечения воспаления в ротовой полости после стоматологической хирургической операции
EP2968422A1 (en) * 2013-03-14 2016-01-20 Nestec S.A. Lactobacillus plantarum ncc 2936 preparations and oral health
TWI505832B (zh) 2014-02-21 2015-11-01 Genmont Biotech Inc 乳酸菌、其組合物與彼等於治療自體免疫疾病暨其倂發症之用途
US9587284B2 (en) 2014-02-21 2017-03-07 Asian Probiotics and Prebiotics Ltd. Lactic acid bacterium having immunomodulatory and anti-allergic effects and pharmaceutical composition containing the same
US9399048B2 (en) 2014-03-05 2016-07-26 Asian Probiotics And Prebiotics Ltd Lactic acid bacteria and its applications in immunomodulation and anti-inflammation

Also Published As

Publication number Publication date
MX393766B (es) 2025-03-21
US20190037902A1 (en) 2019-02-07
CL2018001936A1 (es) 2019-08-02
CN108738308B (zh) 2021-04-30
MX2018008857A (es) 2019-03-06
CA3011322A1 (en) 2017-07-27
DK3405263T3 (en) 2021-05-17
BR112018014654B1 (pt) 2022-06-28
CA3011322C (en) 2023-06-27
SG11201806057QA (en) 2018-08-30
PL3405263T3 (pl) 2021-09-20
RS61954B1 (sr) 2021-07-30
RU2018129759A3 (enExample) 2020-03-26
AU2017209867A1 (en) 2018-08-09
KR20180101491A (ko) 2018-09-12
ES2875765T3 (es) 2021-11-11
PT3405263T (pt) 2021-06-14
PH12018550110B1 (en) 2024-01-31
US10893695B2 (en) 2021-01-19
CN108738308A (zh) 2018-11-02
AU2017209867B2 (en) 2022-01-20
GB201600975D0 (en) 2016-03-02
BR112018014654A2 (pt) 2018-12-11
EP3405263A1 (en) 2018-11-28
ZA201804863B (en) 2022-03-30
EP3405263B1 (en) 2021-03-10
WO2017125446A1 (en) 2017-07-27
JP2019506181A (ja) 2019-03-07
KR102904068B1 (ko) 2025-12-24
PH12018550110A1 (en) 2019-03-18
RU2018129759A (ru) 2020-02-20
NZ744551A (en) 2025-08-29
RU2729420C2 (ru) 2020-08-06
JP6899400B2 (ja) 2021-07-07

Similar Documents

Publication Publication Date Title
PH12018550110A1 (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
MX2021010868A (es) Bacteria de la familia christensenellaceaeas en la prevencion y/o tratamiento de enfermedades inflamatorias cronicas y/o enfermedades gastrointestinales inflamatorias y/o canceres.
WO2018013583A3 (en) Medicinal vaginal lactobacillus cocktail
PH12019502340A1 (en) Probiotic molecules for reducing pathogen virulence
MX2016014807A (es) Singenes de alfa(1,2)fucosiltransferasa para su utilizacion en la produccion de oligosacaridos fucosilados.
PH12018502042B1 (en) Use of probiotics in the treatment and/or prevention of psoriasis
SA519400920B1 (ar) استخدام المعززات الحيوية في علاج و/أو الوقاية من التهاب الجلد التأتبي
MX2023000736A (es) Productos microbianos alimentados en directo.
MX2016014991A (es) Composiciones que contienen acido borico y una mezcla de lactobacilos.
WO2015121458A3 (fr) Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149
PH12019501629A1 (en) Probiotic compositions and uses therof
MX2020001632A (es) Composiciones que comprenden cepas bacterianas.
WO2021004958A3 (en) Compositions comprising bacterial strains
MX2017007969A (es) Bacterias de acido lactico y su uso para el tratamiento de mastitis.
RS66940B1 (sr) Soj lactobacillus salivarus i njegova upotreba u prevenciji i lečenju dijareje nakon odbijanja kod prasadi
MX2020013860A (es) Composiciones probioticas y sus usos.
WO2019220329A8 (en) Probiotic strain lactobacillus kefiri sgl 13 and use thereof for the prevention and treatment of intestinal inflammation and in the prevention of intestinal neoplasms
MX2020001501A (es) Streptococcus australis como bioterapeuticos.
MX2020007906A (es) Composicion que comprende nuevas cepas de lactobacillus salivarius y metodo para la prevencion y el tratamiento de otitis e infecciones respiratorias de vias altas.
MY193625A (en) Probiotic composition for treatment or prevention of high blood cholesterol
WO2019220328A8 (en) Lactobacillus amylovorus sgl 14: probiotic activity and reduction of enteric oxalate
HK40000927A (en) Novel probiotic bacterial strain of lactobacillus plantarum and compositions and uses thereof in the treatment of inflammation
UA120331U (uk) Пробіотик "болмол"
RU2015107472A (ru) Штамм бактерий Lactobacillus acidophilus Т-193, используемый при приготовлении ацидофильной закваски ("Ульцерин"), а также других лечебно-профилактических продуктов для лечения дисбактериоза и его последствий